The results demonstrate that inhibition of endogenous ASB16-AS1 significantly promotes adrenocortical carcinoma cell proliferation in vitro as determined by CCK-8 and EdU incorporation assay (Fig. 2b–d). This evidence concerns the gene ASB16 and adrenal cortex carcinoma.